Reported Jan 17, 2018 · Terminated

Valsartan Tablets, USP, 160 mg, 90-count bottles, Rx Only, Manufactured by

Prinston Pharmaceutical Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Prinston Pharmaceutical Inc · 2002 Eastpark Blvd · Cranbury, NJ · 08512-3514

Is this the product you have?

Valsartan Tablets, USP, 160 mg, 90-count bottles, Rx Only, Manufactured by

3 of 3 products

Products covered by this recall
#Product as published
1Zhejiang Huahai Pharmaceutical Co., Ltd, Xunqiao, Linhai, Zhejiang 317024, China
2Distributed by: Solco Healthcare US, LLC, Cranbury, NJ 08512, USA
3NDC 43547-369-09.
Lot codes and dates
    • Lot #: 343B17025
    • Exp 03/31/19
Amount recalled
21,987 bottles

Where it was sold

  • Nationwide
  • PR

Why it was recalled

Failed Tablet/Capsule Specifications: confirmed customer complaint of thicker and heavier tablets in bottle.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Prinston Pharmaceutical Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Aug 16, 2019 · Data as of Sep 19, 6:33 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.